The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 1.10

Age Distribution (%) of Incidence Cases by Site, 2012-2016
All Races, Both Sexes

Site Ages <20 Ages 20-34 Ages 35-44 Ages 45-54 Ages 55-64 Ages 65-74 Ages 75-84 Ages 85+ All Ages Number of Cases
All Sites 1.0 2.8 4.9 12.9 24.4 27.6 18.3 8.1 100.0% 2,876,963
Oral Cavity & Pharynx: 0.4 1.9 4.3 16.8 30.9 25.4 14.0 6.3 100.0% 75,483
Lip 0.1 1.3 3.3 12.9 22.0 24.7 22.1 13.7 100.0% 4,076
Tongue 0.1 1.7 3.8 16.3 33.6 26.9 13.0 4.6 100.0% 23,285
Salivary gland 1.8 6.1 6.8 12.8 18.9 23.5 18.4 11.7 100.0% 8,345
Floor of mouth 0.2 0.3 2.2 17.2 34.2 26.9 14.2 4.8 100.0% 3,240
Gum & other oral cavity 0.6 1.9 3.7 11.3 23.3 26.0 20.6 12.7 100.0% 10,065
Nasopharynx 2.1 5.8 12.3 22.7 27.7 18.5 8.4 2.5 100.0% 4,025
Tonsil 0.0 0.3 4.0 24.3 39.9 22.6 7.2 1.6 100.0% 13,644
Oropharynx 0.1 0.4 2.4 17.0 35.7 29.1 11.5 3.7 100.0% 3,174
Hypopharynx 0.0 0.3 1.0 13.5 33.2 30.6 16.6 4.7 100.0% 3,844
Other oral cavity & pharynx 0.2 0.6 2.4 15.0 32.3 27.7 14.6 7.3 100.0% 1,785
Digestive System: 0.3 1.3 3.5 12.7 24.2 26.4 20.8 11.0 100.0% 530,255
Esophagus 0.0 0.4 1.8 9.8 26.9 31.4 20.7 8.9 100.0% 28,434
Stomach 0.1 1.6 4.3 11.7 21.7 26.5 22.5 11.5 100.0% 47,636
Small intestine 0.1 1.7 4.9 14.4 24.7 27.9 19.0 7.2 100.0% 15,387
Colon & Rectum: 0.2 1.7 4.4 15.0 22.2 24.4 20.4 11.7 100.0% 250,162
Colon 0.3 1.6 3.8 12.7 20.2 25.0 22.8 13.6 100.0% 175,113
Rectum 0.0 1.9 5.8 20.6 26.8 22.8 15.0 7.1 100.0% 75,049
Colon & Rectum (Male) 0.2 1.6 4.3 15.7 24.6 25.9 19.1 8.6 100.0% 130,031
Colon & Rectum (Female) 0.3 1.8 4.5 14.3 19.6 22.7 21.9 15.0 100.0% 120,131
Anus, anal canal & anorectum 0.0 1.2 4.9 20.4 31.1 23.2 13.1 6.1 100.0% 12,736
Liver & intrahepatic bile duct 0.8 0.7 1.7 10.7 36.4 27.6 16.0 6.0 100.0% 60,650
Gallbladder 0.0 0.5 2.2 8.5 20.6 28.0 26.3 13.9 100.0% 7,934
Other biliary 0.0 0.6 2.2 8.3 20.2 28.3 26.3 14.0 100.0% 12,217
Pancreas 0.1 0.6 1.8 8.4 22.0 29.2 24.4 13.5 100.0% 84,630
Retroperitoneum 8.4 4.5 5.4 15.8 22.4 24.3 14.4 4.7 100.0% 2,443
Peritoneum, omentum & mesentery 0.4 1.0 2.0 10.1 23.8 33.9 21.0 7.7 100.0% 3,280
Other digestive system 0.1 0.8 2.6 8.6 20.9 26.3 25.2 15.4 100.0% 4,746
Respiratory System: 0.1 0.3 1.1 7.5 22.2 33.4 26.0 9.4 100.0% 382,965
Nose, nasal cavity & middle ear 1.7 3.5 6.8 14.4 23.3 23.7 17.2 9.4 100.0% 4,425
Larynx 0.0 0.4 1.9 13.3 31.2 30.5 17.1 5.6 100.0% 19,953
Lung & bronchus 0.0 0.2 1.0 7.0 21.7 33.7 26.7 9.6 100.0% 357,295
Lung & bronchus (Male) 0.0 0.2 0.9 6.7 22.6 34.4 26.4 8.8 100.0% 181,992
Lung & bronchus (Female) 0.0 0.2 1.1 7.4 20.8 32.9 27.0 10.5 100.0% 175,303
Pleura 2.6 2.1 2.1 6.3 16.4 24.9 28.0 17.5 100.0% 189
Trachea & other respiratory organs 16.0 19.6 8.4 10.8 14.0 14.3 11.8 5.2 100.0% 1,103
Bones & joints 26.6 15.0 9.1 12.2 13.8 11.8 7.7 3.7 100.0% 5,749
Soft tissue (including heart) 7.9 9.1 8.3 13.7 19.3 18.9 14.9 7.9 100.0% 21,612
Skin (excl. basal & squamous): 0.5 5.3 7.1 13.9 21.8 24.0 18.0 9.4 100.0% 155,443
Melanoma of the skin 0.4 5.4 7.3 14.4 22.5 24.1 17.4 8.6 100.0% 142,610
Other non-epithelial skin 1.2 4.9 5.3 8.3 14.9 22.8 25.1 17.6 100.0% 12,833
Breast (Female) 0.0 1.9 8.4 20.1 25.6 24.8 13.7 5.6 100.0% 437,722
Breast (Female -in situ) 0.0 0.8 9.7 26.9 27.6 23.7 9.6 1.8 100.0% 112,119
Female Genital System: 0.3 3.7 7.6 16.8 29.0 24.5 12.6 5.5 100.0% 177,691
Cervix uteri 0.1 13.4 23.0 22.9 19.7 11.9 6.3 2.7 100.0% 22,610
Corpus uteri 0.0 1.5 5.0 15.6 34.5 28.2 11.5 3.6 100.0% 95,900
Uterus, NOS 0.2 1.9 5.4 14.7 23.4 23.7 17.3 13.4 100.0% 3,009
Ovarya 1.3 4.0 6.7 17.5 24.7 22.6 15.3 7.9 100.0% 39,543
Vagina 0.9 1.3 4.7 12.9 21.6 26.4 20.2 12.1 100.0% 2,382
Vulva 0.1 1.5 5.0 13.9 19.8 22.4 21.9 15.4 100.0% 8,934
Other female genital system 0.5 3.6 3.4 12.7 25.4 28.7 17.9 7.9 100.0% 5,313
Male Genital System: 0.3 2.3 1.5 8.9 31.3 37.4 14.3 3.9 100.0% 365,266
Prostate 0.0 0.0 0.5 8.7 32.7 39.2 14.9 4.0 100.0% 345,138
Testis 5.3 50.4 23.1 13.1 5.6 1.7 0.6 0.2 100.0% 16,789
Penis 0.0 1.8 4.8 11.6 19.7 27.1 23.9 11.2 100.0% 2,559
Other male genital system 1.4 3.3 3.5 11.5 22.6 29.6 19.6 8.5 100.0% 780
Urinary System: 0.5 1.1 3.3 10.0 21.8 29.1 23.2 11.0 100.0% 240,807
Urinary bladder 0.1 0.4 1.3 6.0 18.1 30.2 28.7 15.1 100.0% 130,091
Kidney & renal pelvis 1.1 1.9 5.9 15.4 26.7 27.7 15.9 5.6 100.0% 104,821
Ureter 0.1 0.1 0.4 4.0 14.4 29.9 34.9 16.2 100.0% 3,376
Other urinary system 0.1 0.4 1.3 6.3 16.7 27.5 28.3 19.4 100.0% 2,519
Eye & Orbit 10.8 3.8 6.0 12.7 22.7 23.4 14.7 5.9 100.0% 5,560
Brain & Nervous System: 12.2 8.9 7.6 13.0 20.4 19.8 13.0 5.1 100.0% 39,632
Brain 11.2 8.8 7.4 12.9 20.8 20.3 13.4 5.2 100.0% 37,213
Cranial nerves & other nervous system 27.7 10.6 10.3 14.1 14.7 11.8 6.7 4.1 100.0% 2,419
Endocrine System: 2.7 15.3 17.9 22.2 21.1 14.0 5.5 1.3 100.0% 101,150
Thyroid 1.8 15.8 18.4 22.6 21.1 13.8 5.3 1.2 100.0% 96,253
Other endocrine & thymus 19.6 6.6 8.0 13.1 21.0 18.0 10.5 3.1 100.0% 4,897
Lymphoma: 2.8 6.8 6.1 11.9 20.3 24.1 19.3 8.7 100.0% 141,683
Hodgkin lymphoma 12.0 31.5 13.7 12.7 12.1 9.7 6.2 2.1 100.0% 15,829
Non-Hodgkin lymphoma 1.7 3.6 5.1 11.8 21.3 26.0 20.9 9.6 100.0% 125,854
Myeloma 0.0 0.5 2.7 10.6 23.2 30.2 23.5 9.4 100.0% 45,190
Leukemia: 7.9 4.5 4.5 9.6 18.1 23.9 20.5 11.1 100.0% 88,755
Lymphocytic: 11.9 2.7 3.0 9.0 19.4 24.5 19.1 10.4 100.0% 44,756
Acute lymphocytic 54.2 10.9 6.0 7.3 8.9 6.9 4.1 1.8 100.0% 9,739
Chronic lymphocytic 0.0 0.3 1.6 8.8 22.3 30.0 23.9 13.0 100.0% 32,445
Other lymphocytic 1.0 2.0 9.4 17.9 22.8 22.0 15.2 9.6 100.0% 2,572
Myeloid & Monocytic: 3.8 6.4 6.1 10.4 17.1 23.9 21.7 10.7 100.0% 40,818
Acute myeloid 4.5 5.7 5.3 9.1 16.8 25.1 22.7 11.0 100.0% 26,824
Chronic myeloid 2.0 7.9 8.1 13.5 18.0 21.5 19.4 9.6 100.0% 11,858
Acute monocytic 5.7 5.1 6.5 10.0 17.3 22.7 22.3 10.5 100.0% 1,202
Other myeloid & monocytic 3.4 6.6 5.1 8.5 14.9 22.1 23.3 16.1 100.0% 934
Other leukemia: 5.2 4.9 4.5 7.8 11.3 17.0 23.3 26.0 100.0% 3,181
Other acute leukemia 7.6 5.9 3.7 6.7 11.2 18.4 24.6 21.9 100.0% 1,413
Aleukemic, subleukemic & NOS 3.4 4.1 5.1 8.7 11.3 15.8 22.3 29.2 100.0% 1,768
Kaposi Sarcoma 0.2 22.3 17.4 20.9 12.1 9.6 10.0 7.5 100.0% 3,080
Mesothelioma 0.0 1.0 1.9 5.4 14.1 28.6 32.6 16.4 100.0% 5,736
Ill-defined & unspecified 0.4 0.9 2.0 7.4 18.3 24.0 25.7 21.4 100.0% 49,525

Footnotes:

Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts). Percents may not sum to 100 due to rounding.

a Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.